This study examined the anti-viral effect of ursolic acid on guinea pig cytomegalovirus (GPCMV) and explored the steps of viral replication targeted by ursolic acid. Cytopathic effect assay and MTT method were employe...This study examined the anti-viral effect of ursolic acid on guinea pig cytomegalovirus (GPCMV) and explored the steps of viral replication targeted by ursolic acid. Cytopathic effect assay and MTT method were employed to determine the 50% cellular cytotoxicity (CC50), 50% effective concentration (EC50) and therapeutic index (TI) with GPCMV. To investigate the specific anti-viral effect of ursolic acid at different temperatures and time points, two other medicines, ganciclovir and Jinyebaidu (JYBD), serving as controls, were studied for comparison. Our results showed that the CC50 of ganciclovir, JYBD and ursolic acid were 333.8, 3015.6, 86.7 μg/mL, respectively; EC50 of ganciclovir, JYBD and ursolic acid was 48.1, 325.5 and 6.8 μg/mL, respectively; TI of ganciclovir, JYBD and ursolic acid was 7, 9, 13, respectively. Similar with ganciclovir, ursolic acid could inhibit the viral synthesis, but did not affect the viral adsorption onto and penetration into cells. We are led to conclude that the anti-cytomegalovirus effect of ursolic acid is significantly stronger than ganciclovir or JYBD, and the cytotoxic effect of ursolic acid lies in its ability to inhibit viral synthesis.展开更多
探讨大菱鲆病毒疫苗的研制,以牙鲆鳃细胞(FG细胞)为增殖体系,利用细胞病变效应(CPE)为判断指标,对大菱鲆红体病虹彩病毒(Turbot reddish body iridovirus,TRBIV)的体外最适增殖条件等进行了研究。结果表明,病毒接种量、病毒吸附时间、...探讨大菱鲆病毒疫苗的研制,以牙鲆鳃细胞(FG细胞)为增殖体系,利用细胞病变效应(CPE)为判断指标,对大菱鲆红体病虹彩病毒(Turbot reddish body iridovirus,TRBIV)的体外最适增殖条件等进行了研究。结果表明,病毒接种量、病毒吸附时间、细胞培养条件对TRBIV的体外增殖均有明显的影响,以0.2 mL病毒液接种FG细胞、吸附2 h、用含10%胎牛血清的MEM培养液于22℃培养时,病毒的增殖速度最快。研究还发现,病毒的收获时间和病毒液冻融次数对所得病毒的感染力均有显著影响,在最佳增殖条件下,病毒在FG细胞中增殖至第4天时进行收获,且只冻融1次,其感染活性最强,反复冻融后病毒的感染活性会显著降低。展开更多
基金supported by a grant from the National Natural Science Foundation of China(No.30672243 and No.30671093)Natural Science Foundation of Hubei Province of China (No. 2009CDB216)
文摘This study examined the anti-viral effect of ursolic acid on guinea pig cytomegalovirus (GPCMV) and explored the steps of viral replication targeted by ursolic acid. Cytopathic effect assay and MTT method were employed to determine the 50% cellular cytotoxicity (CC50), 50% effective concentration (EC50) and therapeutic index (TI) with GPCMV. To investigate the specific anti-viral effect of ursolic acid at different temperatures and time points, two other medicines, ganciclovir and Jinyebaidu (JYBD), serving as controls, were studied for comparison. Our results showed that the CC50 of ganciclovir, JYBD and ursolic acid were 333.8, 3015.6, 86.7 μg/mL, respectively; EC50 of ganciclovir, JYBD and ursolic acid was 48.1, 325.5 and 6.8 μg/mL, respectively; TI of ganciclovir, JYBD and ursolic acid was 7, 9, 13, respectively. Similar with ganciclovir, ursolic acid could inhibit the viral synthesis, but did not affect the viral adsorption onto and penetration into cells. We are led to conclude that the anti-cytomegalovirus effect of ursolic acid is significantly stronger than ganciclovir or JYBD, and the cytotoxic effect of ursolic acid lies in its ability to inhibit viral synthesis.